tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Geoff Meacham, 93 are a HOLD (26.42%), 234 are a BUY (66.48%), 25 are a SELL (7.1%).
Analyst Geoff Meacham, currently employed at CITI, carries an average stock price target met ratio of 62.31% that have a potential upside of 31.42% achieved within 244 days.
Geoff Meacham’s has documented 786 price targets and ratings displayed on 59 stocks. The coverage is on Healthcare, Technology sectors.
Most recent stock forecast was given on PFE, Pfizer at 02-Dec-2025.
Analyst best performing recommendations are on LYEL (LYELL IMMUNOPHARMA).
The best stock recommendation documented was for LYEL (LYELL IMMUNOPHARMA) at 10/30/2024. The price target of $20 was fulfilled within 2 days with a profit of $2.84 (16.55%) receiving and performance score of 82.75.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
Since 05-May-2021
$205
$22.5 (12.33%)
4 years 8 months 2 days ago
(05-May-2021)
3/5 (60%)
$35.09 (20.65%)
938
Hold
Since 23-Mar-2021
$173
$-9.5 (-5.21%)
$156
4 years 8 months 4 days ago
(03-May-2021)
14/24 (58.33%)
$2.73 (1.60%)
682
Hold
Since 14-Dec-2020
$190
4 years 8 months 12 days ago
(26-Apr-2021)
9/11 (81.82%)
$34.41 (22.12%)
350
Buy
Since 06-Sep-2019
$175
$-7.5 (-4.11%)
$165
4 years 11 months 3 days ago
(04-Feb-2021)
3/3 (100%)
$19.41 (12.48%)
397
Hold
Since 04-Feb-2021
$166
$-16.5 (-9.04%)
$175
4 years 11 months 3 days ago
(04-Feb-2021)
23/23 (100%)
$10.41 (6.69%)
828
Which stock is Geoff Meacham is most bullish on?
Which stock is Geoff Meacham is most reserved on?
What Year was the first public recommendation made by Geoff Meacham?
